This dyslipidemia can lead to an accumulation of fatty acids in tissues such as muscle and liver, which can interfere with insulin signaling and exacerbate insulin resistance, thereby increasing the risk of GDM (35). The gene discussed is INS; the disease is metabolic syndrome.